Evidence map›Paper›PMID 42523858›Full record

SynthesisFrontiers in medicine2026

Risk factors for hospital readmission in chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Hao Tian, Wei Shen, Liuyang Huang, Bowen Feng, Baoyue Hong, Xianzheng Li, Fanrong Liang, Chunyan Yang, Qingguang Qin

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hao Tian *Department of Acupuncture, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Wei Shen *Hainan Medical University, Haikou, Hainan, China.
Liuyang HuangCollege of Acupuncture and Orthopedics, Hubei University of Chinese Medicine; Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibustion; Hubei Shizhen Laboratory, Wuhan, Hubei, China.
Bowen FengDepartment of Acupuncture, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Baoyue HongHainan Medical University, Haikou, Hainan, China.
Xianzheng LiDepartment of Rehabilitation, Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou, Hainan, China.
Fanrong LiangCollege of Acupuncture and Tuina, The Third Teaching Hospital, College of Basic Medicine, College of International Education, Chengdu University of Traditional Chinese Medicine; Clinical Research Center for Acupuncture and Moxibustion in Sichuan Province, Chengdu, Sichuan, China.
Chunyan YangDepartment of Acupuncture and Massage, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.
Qingguang QinDepartment of Acupuncture, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with chronic obstructive pulmonary disease (COPD) commonly experience acute exacerbations that require hospitalization and may lead to repeated COPD-related readmissions. Among patients who survive an index hospitalization, early readmission due to acute exacerbation of COPD remains a major clinical challenge. Therefore, evaluating readmission rates at different follow-up time points and identifying factors associated with readmission are important for improving COPD management. Better risk assessment and early recognition of high-risk patients may support targeted interventions, reduce avoidable readmissions, and improve quality of life and clinical outcomes. Objective: This study aimed to systematically summarize COPD-related readmission rates within 1 month, 3 months, 6 months, and 1 year after hospital discharge, and to identify factors associated with COPD-related readmission. Methods: Eight electronic databases were searched from inception to October 1, 2026, to identify observational studies reporting COPD-related readmission. Methodological quality was assessed using the Newcastle-Ottawa Scale (NOS) for cohort and case-control studies and an adapted NOS for cross-sectional studies. Pooled estimates of readmission rates and factors associated with readmission among patients with COPD were calculated using random-effects models. Results: A total of 54 studies were included, reporting 25 outcome indicators. The pooled readmission rates after discharge were 15.2% within 1 month, 26.90% within 3 months, 30.40% within 6 months, and 42.10% within 1 year. In total, 26 factors associated with readmission were identified. Overall, the methodological quality of the included studies was moderate to high. Conclusion: This meta-analysis examined readmission rates and factors associated with readmission among patients with COPD. The findings show that the 1-year readmission remains common and is influenced by multiple clinical factors. These results underscore the need for early identification of high-risk patients and timely interventions to improve long-term COPD management. Sensitivity analyses showed that the findings were stable, and the included studies were generally of moderate to high methodological quality, supporting the reliability and clinical relevance of the conclusions. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261286213, Identifier CRD420261286213.

Indexed as

chronic obstructive pulmonary diseasehospital readmissionmeta-analysisreadmission raterisk factorssystematic review

Identifiers

PMID42523858
PMCPMC13408023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.